Lisa A. Bukovac, DO, FACOG, explains how placental biomarker testing can identify which patients with suspected preeclampsia require hospitalization and which can be safely monitored.
Lisa A. Bukovac, DO, FACOG
Advertisement
Lisa A. Bukovac, DO, FACOG, Chief clincial officer, Ob Hospitalist Group.
Articles by Lisa A. Bukovac, DO, FACOG
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients
2
Q+A: Connor Frey, MD, on GLP-1 RAs and menstrual adverse event signals
3
Statewide bundle reduces risk for deliveries complicated by postpartum hemorrhage
4
A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD
5